{"contacts": [{"terms": [{"accession": "MS:1002332", "name": "lab head"}, {"accession": "MS:1000586", "name": "contact name", "value": "Frode Berven"}, {"accession": "MS:1000589", "name": "contact email", "value": "fberven76@gmail.com"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Norway"}]}, {"terms": [{"accession": "MS:1002037", "name": "dataset submitter"}, {"accession": "MS:1000586", "name": "contact name", "value": "Astrid Guldbrandsen"}, {"accession": "MS:1000589", "name": "contact email", "value": "astrid.guldbrandsen@uib.no"}, {"accession": "MS:1000590", "name": "contact affiliation", "value": "Proteomics Unit (PROBE), Department of Biomedicine, University of Bergen, Norway"}]}], "description": "We have developed and tested parallel reaction monitoring (PRM) assays for 25 proteins highly relevant as cerebrospinal fluid (CSF) biomarkers for multiple sclerosis, representing various biological processes affected in the disease. The proteins were represented by 72 peptides selected according to relevant guidelines and available literature. Stability testing revealed 64 peptides with low intra- and inter-day variations, with 44 also being stably digested after 16 hours of trypsin digestion, and 37 furthermore showing a significant difference between multiple sclerosis and controls, thereby confirming literature findings. Calibration curves were developed using spike-in of synthetic light and heavy peptides in rat plasma.", "fullDatasetLinks": [{"accession": "MS:1002873", "name": "Panorama Public dataset URI", "value": "https://panoramaweb.org/PRM_Assay_CSF.url"}], "identifiers": [{"accession": "MS:1001919", "name": "ProteomeXchange accession number", "value": "PXD017281"}, {"accession": "MS:1001921", "name": "ProteomeXchange accession number version number", "value": "1"}, {"accession": "MS:1002872", "name": "Panorama Public dataset identifier", "value": "https://panoramaweb.org/PRM_Assay_CSF.url"}], "instruments": [{"accession": "MS:1002523", "name": "Q Exactive HF"}], "keywords": [{"accession": "MS:1001925", "name": "submitter keyword", "value": "parallel reaction monitoring"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "cerebrospinal fluid"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "multiple sclerosis"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "neurological diseases"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "proteomics"}, {"accession": "MS:1001925", "name": "submitter keyword", "value": "biomarker"}], "modifications": [{"accession": "UNIMOD:4", "name": "Carbamidomethyl"}, {"accession": "UNIMOD:259", "name": "Label:13C(6)15N(2)"}, {"accession": "UNIMOD:267", "name": "Label:13C(6)15N(4)"}], "publications": [{"terms": [{"accession": "MS:1000879", "name": "PubMed identifier", "value": "32963504"}, {"accession": "MS:1002866", "name": "Reference", "value": "Guldbrandsen A, Lereim RR, Jacobsen M, Garberg H, Kroksveen AC, Barsnes H, Berven FS. Development of robust targeted proteomics assays for cerebrospinal fluid biomarkers in multiple sclerosis. Clin Proteomics. 2020 Sep 18;17:33. doi: 10.1186/s12014-020-09296-5. PMID: 32963504; PMCID: PMC7499868."}]}], "species": [{"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Rattus norvegicus"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "10116"}]}, {"terms": [{"accession": "MS:1001469", "name": "taxonomy: scientific name", "value": "Homo sapiens"}, {"accession": "MS:1001467", "name": "taxonomy: NCBI TaxID", "value": "9606"}]}], "title": "Parallel reaction monitoring assay development for multiple sclerosis biomarkers in cerebrospinal fluid."}